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Abstract 
Background: Genomic imprinting, resulting in parent-of-origin specific gene expression, plays a critical role in mam-
malian development. Here, we apply allele-specific RNA-seq on isogenic B6D2F1 mice to assay imprinted genes in 
tissues from early embryonic tissues between E3.5 and E7.25 and in pluripotent cell lines to evaluate maintenance of 
imprinted gene expression. For the cell lines, we include embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs) 
derived from fertilized embryos and from embryos obtained after nuclear transfer (NT) or parthenogenetic activation 
(PGA).
Results: As homozygous genomic regions of PGA-derived cells are not compatible with allele-specific RNA-seq, we 
developed an RNA-seq-based genotyping strategy allowing identification of informative heterozygous regions. Global 
analysis shows that proper imprinted gene expression as observed in embryonic tissues is largely lost in the ESC lines 
included in this study, which mainly consisted of female ESCs. Differentiation of ESC lines to embryoid bodies or NPCs 
does not restore monoallelic expression of imprinted genes, neither did reprogramming of the serum-cultured ESCs 
to the pluripotent ground state by the use of 2 kinase inhibitors. Fertilized EpiSC and EpiSC-NT lines largely maintain 
imprinted gene expression, as did EpiSC-PGA lines that show known paternally expressed genes being silent and 
known maternally expressed genes consistently showing doubled expression. Notably, two EpiSC-NT lines show aber-
rant silencing of Rian and Meg3, two critically imprinted genes in mouse iPSCs. With respect to female EpiSC, most of 
the lines displayed completely skewed X inactivation suggesting a (near) clonal origin.
Conclusions: Altogether, our analysis provides a comprehensive overview of imprinted gene expression in pluripo-
tency and provides a benchmark to allow identification of cell lines that faithfully maintain imprinted gene expression 
and therefore retain full developmental potential.
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Background
Embryonic stem cells (ESCs) and epiblast stem cells 
(EpiSCs) are pluripotent cells derived from mouse 
embryos at embryonic day (E) E3.5–E4.5 and E6–E7, 
respectively [1–4]. Both ESCs and EpiSCs can be directed 
to differentiate into a wide variety of mature cell types. 
Therefore, these cells are important models for pre- and 
post-implantation embryonic development. As mouse 
ESCs are highly amenable to genetic manipulation and 
are capable of colonizing the germline of chimaeric mice 
[5], they are widely used for the generation of transgenic 
mice.
ESCs and EpiSCs are also promising tools in regenera-
tive medicine due to their self-renewal and differentiation 
capacity. To avoid an allogeneic immune response dur-
ing transplantation of these cells, a matching genotype 
between donor and recipient cells is of key importance. 
Induced pluripotency has emerged as one of the main 
methodologies to derive patient-specific pluripotent 
cells (iPSCs) by reprogramming of adult stem cells using 
defined reprogramming factors [6]. Two more traditional 
approaches to obtain genetically matched pluripotent 
cells include somatic cell nuclear transfer (NT) and par-
thenogenetic activation (PGA) [7, 8]. During NT, the 
nucleus of a donor cell is introduced into an enucleated 
oocyte, after which ESC-NTs or EpiSCs-NTs are derived 
from the developing embryo. NT is a relatively inefficient 
process, but it has a significant advantage over transcrip-
tion factor-mediated reprogramming in that ESC-NTs 
largely lack residual parental DNA methylation patterns 
as observed for iPSCs [9]. PGA involves the stimulation 
of oocytes to produce diploid ESC-PGAs in the absence 
of fertilization [8]. Although the genotype of the ESC-
PGA cells is different from the female oocyte donor due 
to meiotic recombination occurring in the oocyte, sub-
sequent matching of the ESC-PGAs based on the major 
histocompatibility complex antigens allows for engraft-
ment of these cells in mouse recipients [10].
Genomic imprinting is an epigenetic process result-
ing in the expression of genes in a parent-of-origin spe-
cific manner. Current estimates suggest the presence of 
around 200 imprinted genes in mice, most of them hav-
ing a role in development and social cognition [11, 12]. 
The importance of imprinting during embryonic devel-
opment is further underpinned by the fact that andro-
genetic mice (derived from two paternal pronuclei) and 
gynogenetic mice (derived from two maternal pronuclei) 
are embryonic lethal [13, 14]. This is associated with the 
imprinted H19 and Dlk1-Dio3 loci, as manipulation of 
these loci enables the generation of viable and fertile bi-
maternal mice [15]. In line with this, proper imprinting 
of the Dlk1-Dio3 locus in iPSCs is essential for signifi-
cant contribution to chimaeras and for the derivation of 
viable all-iPSC mice [16]. Together, these studies show 
that maintenance of imprinted genes in embryonic cells 
is essential to retain full developmental potential. Addi-
tionally, loss of imprinting is highly correlated with trans-
formation and cancer [17, 18], further highlighting the 
importance of assaying imprinted loci of cells.
Considering the critical role of imprinting in develop-
ment [19], imprinted genes in ESC and EpiSC lines have 
been assayed in previous studies. This showed that mouse 
ESCs tend to lose imprinting upon prolonged culturing 
resulting in only few genes showing imprinted expression 
[20–23], while EpiSCs retain their imprints [24]. In con-
trast to EpiSCs from normal fertilized mouse embryos, 
EpiSCs derived from NT were reported to show aber-
rant expression of imprinted genes [25]. With regard to 
parthenogenesis, ESC-PGA cells were reported to show 
a surprisingly high efficiency in their contribution to chi-
maeric mice. This has been attributed to a loss of aberrant 
imprinting in the ESC-PGA cells [26], but this analysis 
was based on a very small number of loci. Interestingly, 
in human loss of imprinting in conventional ESCs is rela-
tively rare, but occurs much more frequently in human 
ESC-NTs and iPSCs [27]. Most of the studies assaying 
imprinted genes were performed on a restricted panel 
of imprinted genes, or in a non-allele-specific manner 
(i.e., without the knowledge if a gene is expressed from 
the maternally or paternally derived allele). There is only 
few studies that include profiling of imprinting in embry-
onic tissues, which is important for comparative analy-
sis of ESC lines or EpiSC lines with their founder cells. 
Therefore, a global overview of allele-specific expression 
of imprinted genes, and how this contributes to the func-
tionality of the ESCs and EpiSCs, is currently lacking.
To study the degree to which imprinted gene expres-
sion is preserved in pluripotent cell lines as compared 
to their founder mouse embryonic cells in vivo, we per-
formed high-resolution allele-specific RNA-seq on 
embryonic tissues as well as on ESCs and EpiSCs derived 
after normal fertilization, NT and PGA. For the embry-
onic tissues, we focused on the very early embryonic 
stages (between E3.5 and E7.25 [28]) from which ESCs 
and EpiSCs are derived. Although two recent studies per-
formed in-depth analysis of allelic gene expression dur-
ing embryonic development, these studies focused on 
much later stages (from E9.5 onward) [11, 20]. Further-
more, previous studies were carried out on a variety of 
mouse genetic backgrounds, which is known to influ-
ence the efficiency of ESC derivation and to affect NT 
and PGA [29–32]. In our study, we make use of isogenic 
F1 hybrids of C57BL/6J (maternal) and DBA/2J (pater-
nal) mouse inbred strains, previously also referred to 
as B6D2F1, B6D2 or BDF1. This cross has been shown 
to be relatively efficient in NT and PGA, and the use of 
Page 3 of 21Dirks et al. Epigenetics & Chromatin           (2019) 12:14 
isogenic tissues and cell lines eliminates complications 
arising from strain-specific differences in gene expression 
[30, 31, 33]. Importantly, when derived from hybrid F1 
mice, ESC-PGAs contain a mosaic homo- and heterozy-
gous genotype due to chromosomal crossover occurring 
in the parental B6D2F1 oocyte during meiosis [10]. Since 
only the heterozygous part of the genome is compatible 
with allele-specific expression in RNA-seq, we devel-
oped a robust algorithm to reconstruct genotypes of cells 
derived by PGA based on the RNA-seq profiles we gener-
ated. This allowed us to gain insight in allele-specific gene 
expression of PGA cells at a global scale for the first time.
Results
Experimental setup to study imprinted gene expression 
using allele‑specific RNA‑seq
To assay imprinted genes during embryogenesis and 
in the ESCs and EpiSCs, we made use of the B6D2F1 
mouse model (Fig. 1a). Being an intercross of the geneti-
cally distant inbred strains C57BL/6J (referred to in this 
manuscript as B6) and DBA/2J (referred to as DBA2), the 
B6D2F1 mice contain around 5.2 million single nucleo-
tide polymorphic sites (SNPs) genome-wide, correspond-
ing to ~ 1 SNP per 520  bp [34–37]. These sites can be 
used to discriminate between expression from either the 
B6 maternally or the DBA2 paternally derived alleles in 
B6D2F1 cells by RNA-seq profiling.
To gain insight into the expression of imprinted genes 
in the developing B6D2F1 embryo in vivo, we used RNA-
seq that we generated previously [28] on three replicate 
tissues of (1) Expanded Blastocyst: Inner cell mass (E3.5; 
“EBI”); (2) Epithelial cells of the pre-gastrulation Radi-
ally Symmetrical Epiblast (E6.25; “ERSE”); and (3) mid-
gastrulation Anterior–Posterior Epiblast (E7.25; “APE”). 
Given the importance of imprinting in the placenta 
[38], Expanded Blastocyst: mural TrophEctoderm tissue 
(E3.5; “EB-TE”; two replicates), we performed RNA-seq 
profiling to provide insight into imprinted gene expres-
sion in the very early extraembryonic trophoblast lineage 
(Fig. 1a, b; Additional file 1: Table S1). With regard to the 
pluripotent cell lines, we performed RNA-seq on con-
ventional B6D2F1 ESCs derived from fertilized embryos 
(two lines, referred to as ESC or fertilized ESC). We also 
included three ESC lines derived from nuclear trans-
fer embryos generated using B6D2F1 mouse embryonic 
fibroblast donor nuclei (ESC-NT1) or B6D2F1 donor 
nuclei of cumulus cells (ESC-NT2 and ESC-NT3), as well 
as three ESC lines derived from PGA embryos generated 
using B6D2F1 oocytes (ESC-PGA) (Fig.  1a; Additional 
file  1: Table  S1). Similarly, three replicas of fertilized 
B6D2F1 EpiSC lines and EpiSC lines derived from nuclear 
transfer embryos generated using a B6D2F1 donor nuclei 
of cumulus cells (EpiSC-NT) were included for RNA-seq 
(Fig. 1a; Additional file 1: Table S1). Lastly, we included 
two EpiSC-PGA lines which were previously described 
as EpiSC-NT lines [25], but which we here confirm to be 
of PGA origin (as further outlined below). As prolonged 
culture of ESCs has recently been associated with erosion 
of genomic imprints [39, 40], we used early passage ESCs 
(between passage 8 and 14; Additional file  1: Table  S1). 
Using regular (non-allele specific) expression analysis of 
the RNA-seq, we validated the developmental stages of 
the samples and the RNA-seq profiling (Additional file 2: 
Fig. S1 and Fig. S2).
Genotyping of PGA samples using RNA‑seq profiling
Cells containing a B6D2F1 genotype, such as the embry-
onic tissues and most of the cell lines included in this 
study, are compatible with global allele-specific analy-
sis by RNA-seq. However, only part of the genome of 
B6D2F1-derived ESC-PGA lines can be utilized to call 
allele-specific expression using RNA-seq. During the 
most widely used method  for PGA (resulting in p(MII)
ESCs referred here as ESC-PGAs), metaphase II-halted 
oocytes are stimulated to proceed through meiosis in 
the absence of fertilization. Blocking the extrusion of the 
second polar body results in a diploid parthenote. Sub-
sequent chemical activation toward further development 
(See figure on next page.)
Fig. 1 Setup of our study including reconstruction of PGA genotypes using allele-specific RNA-seq. a Mouse strains and crosses used to derive 
the B6D2F1 samples as profiled by RNA-seq. b Embryos were collected at different stages of development (top) and microdissected for RNA-seq 
as shown in the illustration (bottom) [28]. The epiblast is depicted in shades of pink, trophectoderm is in gray, extraembryonic endoderm is light 
brown, and extraembryonic mesoderm is dark brown. Dashed lines show the cells dissected for total RNA isolation. c Genotype of ESC lines as 
determined by allele-specific RNA-seq at 5 MB resolution. The horizontal axis represents chromosomes, and the vertical axis chromosomal bins (per 
5 MB). The numbers within each bin (also categorized by the three colors) represent the percentage B6 as compared to the total coverage of B6 and 
DBA2. The panel of ESC1 shows the position of imprinted gene clusters that are included in follow-up analysis (Fig. 2). Additional file 2: Fig. S3 shows 
the genotype of all 8 B6D2F1 ESC lines profiled. d Distribution of relative expression of the B6 versus the DBA2 allele of the genes present within 
genomic regions genotyped as either homozygous B6 (red), heterozygous B6/DBA2 (blue) or homozygous DBA2 (yellow) in the ESC-PGAs. A log2 
ratio of 0 represents equal biallelic gene expression from the B6 and DBA2 alleles, while positive and negative ratios represent higher expression 
from the B6 or DBA2 allele, respectively. e Similar to panel c, but showing EpiSC lines. Additional file 2: Fig. S5 shows the RNA-seq-based genotyping 
of all 8 DBA2 EpiSC lines profiled
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allows for derivation of ESC-PGAs [8]. Metaphase II 
oocytes have already undergone meiotic recombination, 
and therefore, the genotype of the subsequent ESC-PGA 
cells is different from the female oocyte donor: B6D2F1 
ESC-PGA lines are homozygous proximal to the cen-
tromere, while they are heterozygous at distal regions for 
most chromosomes [10]. The homozygous parts of the 
genome of the PGA lines lack SNPs required for allele-
specific RNA-seq analysis. Thus, only the heterozygous 
parts of the genome of PGA lines can be utilized to call 
allele-specific expression. To identify these heterozy-
gous parts, we used the allele-specific RNA-seq mapping 
counts over the B6/DBA2 polymorphic sites to calcu-
late the relative contribution of either B6 (maternal) or 
DBA2 (paternal) in genomic bins, on which we applied 
a moving average over the individual chromosomes. 
Since we expect only 1 or few breakpoints per chro-
mosome, we first analyzed at a low resolution to gain a 
comprehensive overview. Using a low-resolution bin-
ning size of 5 Mb (Fig. 1c), this RNA-seq SNP genotyp-
ing very clearly shows a pattern of recombination in all 
the ESC-PGAs. In contrast, the fertilized ESCs and ESC-
NTs show a full heterozygous F1 genotype as expected 
(Fig. 1c, Additional file 2: Fig. S3). To better estimate the 
chromosomal breakpoints, we increased our resolution 
to 1 MB (Additional file 3: Table S2). Plotting of the allelic 
ratios of genes present within the parts of the genome 
in ESC-PGAs annotated as either B6, heterozygous or 
DBA2 shows the expected pattern (Fig.  1d). Genes pre-
sent in the heterozygous part of the genome are largely 
expressed from both alleles, while alleles of genes present 
in the homozygous part of the genome cannot be dis-
criminated. Therefore, these genes show a (near) com-
plete bias according to their genotype. Together, this 
allowed us to only include genes present in the informa-
tive heterozygous parts in the genome (Additional file 3: 
Table  S2) for further allele-specific RNA-seq analysis of 
the PGA lines.
To verify the genotype of the remaining embryonic tis-
sues and EpiSC samples, we applied the same RNA-seq-
based genotyping strategy. The in vivo embryonic tissues 
showed the expected heterozygous F1 genotype, except 
for the maternal B6 bias on the X chromosome which 
reflects the presence of male embryos in the pooled 
male and female embryos samples (Additional file  2: 
Fig. S4). All fertilized EpiSC and three of the EpiSC-NT 
lines also showed the expected F1 genotype as expected 
(Additional file  2: Fig. S5). Additionally, we identified 
two parthenogenetic EpiSC lines (Fig. 1e). These EpiSC-
PGA lines have originally been reported as being derived 
after transfer of B6D2F1 donor nuclei of cumulus cells 
[25]. Nevertheless, they show a clear mosaic genotype, 
not matching the expected F1 genotype as observed for 
the other three EpiSC-NT lines (Additional file  2: Fig. 
S5). Instead, these two EpiSC lines show a recombina-
tion pattern unique to PGA (Fig. 1e; cf Fig. 1c). To verify 
these two unexpected genotypes, we performed regular 
genotyping using genomic DNA, yielding results nearly 
identical to the RNA-seq genotyping, both at 5 MB reso-
lution (Additional file 2: Fig. S6; cf Additional file 2: Fig. 
S5) and at 1 MB resolution (Additional file 4: Table S3). 
This further confirms the mosaic PGA-specific genotypes 
for both EpiSC lines, and these lines were included in 
this study accordingly. The accidental isolation of PGA-
derived cells during nuclear transfer experiments is a 
serious concern [41] and is likely due to improper enu-
cleation preceding the nuclear transfer resulting in PGA 
of the original nucleus after stimulation of the oocyte.
Finally, to validate our RNA-seq-based genotyping 
approach, we made further use of the direct comparison 
with regular DNA-based genotyping. At 1  MB resolu-
tion, the RNA-seq genotyping algorithm identified the 
exact same position of genomic breakpoints in 56% (23 
of 41) of the cases as compared to DNA-based genotyp-
ing, while it shows an average accuracy of 2.9 MB in the 
EpiSC-PGAs (Additional file  4: Table  S3). Notably, our 
RNA-seq-based genotyping algorithm also allows for 
identification of genomic alterations (Additional file  2: 
Fig. S8). Together, this shows the accuracy and sensitiv-
ity of our RNA-seq-based genotyping approach and fur-
ther  confirms our detection of  the heterozygous parts 
of the PGA cell lines to be used in further analysis for 
imprinting.
Allele‑specific expression of imprinted genes in embryonic 
tissues
For allele-specific expression, we applied a computational 
pipeline for unbiased allele-specific quantification of 
transcripts that we developed previously, obtaining quan-
titative allelic information for up ~ 5000 genes per sam-
ple (Additional file 2: Fig. S9) [42]. On average, individual 
genes show equal expression from the B6- and DBA2-
derived alleles in all samples, including in the heterozy-
gous chromosomal regions of the PGA-derived lines, 
with only a small number of genes showing allelic bias 
in expression toward B6 or DBA2 as would be expected 
for imprinted genes (Additional file 2: Fig. S9). To deter-
mine allele-specific expression of imprinted genes, we 
compiled a list of 98 imprinted genes based on avail-
able data present in the two most widely used imprint-
ing databases (www.genei mprin t.com [43] and www.har.
mrc.ac.uk/resea rch/genom ic_impri nting / [44]) and in a 
recent comprehensive survey on imprinted genes over 
a large number of developmental stages and tissues [11] 
(Additional file 5: Table S4). Of these 98 genes, 20 genes 
had sufficient RNA-seq coverage over polymorphic sites 
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Fig. 2 Allele-specific expression of imprinted genes in mouse in vivo and in vitro pluripotent states. a Allelic bias in expression of known imprinted 
genes plotted by the percentage of B6 as compared to the total coverage of B6 and DBA2 per gene. Within individual panels, the left axis represents 
expression from the DBA2 (paternal) allele, the right axis represents expression from the B6 (maternal) allele, and the middle axis represents equal 
biallelic expression. The individual replicas of all samples are included in the graph, but not individually labeled. The graph only includes data points 
of genes for which we obtained sufficient coverage to calculate allelic bias, explaining the variable number of data points between genes or the 
complete lack of data points for some genes in either of the cell lines or the embryonic tissue. “P” = paternally expressed; “M” = maternally expressed. 
b Similar to a, showing allelic expression of imprinted genes during differentiation of ESCs toward embryoid bodies (left panel) or NPCs (right panel)
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(> 9 counts [42]) to quantify allele-specific expression 
in at least one of the samples included in our analysis 
(Fig. 2a; Additional file 6: Table S5). Notably, in order to 
obtain reliable allelic ratios, we only included a gene of an 
individual sample in our analysis if it showed consistent 
B6 versus DBA2 allelic ratios over all polymorphic sites 
that are present within the gene body (standard error of 
the mean < 0.15; see Methods section for more details). 
An overview of the RNA-seq data of all B6D2F1 samples 
over a selection of the imprinted genes is provided in 
Additional file 2: Fig. S10.
For the in  vivo embryonic tissues, we obtained allelic 
information for 16 autosomal genes and 1 X-linked 
gene (Xist), while expression of Peg12, Peg10 and 
Plagl1 was too low in any of the samples to reliably call 
allelic ratios (Fig. 2a). From the 16 autosomal imprinted 
genes covered, 13 (81%) follow a pattern of (nearly) full 
imprinting in all samples for which we obtained allelic 
ratios (Fig. 2a). Another two genes (13%) show a strong 
parental bias (> 80%) toward either the maternal (H13) 
or the paternal allele (Phf17), in line with later embry-
onic stages or tissues for which these genes consist-
ently show an allelic bias but not complete monoallelic 
expression [11, 45]. Interestingly, the imprinting pattern 
of the EB-TE trophectoderm samples was nearly iden-
tical to that observed for the other embryonic tissues, 
including the EBI embryoblast tissues obtained from 
the same embryonic stage E3.5. Previous studies focus-
ing on mouse embryonic tissues at later stages (E9.5 and 
later) showed that imprinting of Phf17 was restricted to 
the mouse placenta and yolk salk [11]. Here, we find that 
Phf17 also consistently shows allelic expression bias in 
early mouse embryonic inner cell mass tissue. This sug-
gests that imprinting of Phf17 outside extra-embryonic 
tissue is lost shortly after the blastocyst stage. Ube3a, the 
only gene that consistently shows biallelic expression at 
all embryonic stages profiled, was originally identified 
as being imprinted in brain [46]. Apparently, this gene is 
not imprinted during embryonic development. Finally, it 
should be noted that the individual in vivo embryonic tis-
sues originate from a pool of male and female embryos, 
which complicates interpretation of allelic ratios of 
the X-linked gene Xist for these samples. Together, 
these results show that we robustly detect imprinting 
in B6D2F1 early (extra-)embryonic tissue for nearly all 
known imprinted genes covered in our transcriptomes, 
extending previous observations of highly conserved 
imprinting pattern across tissues [11] to early embryonic 
and extra-embryonic tissues.
Allele‑specific expression of imprinted genes in ESCs
Most of the ESC lines, either fertilized ESCs, ESC-NTs 
or ESC-PGAs, show a very different pattern of imprinted 
gene expression as compared to the in  vivo embryonic 
tissues, including the E3.5 inner cell mass tissue that they 
originate from (Fig.  2a). In the fertilized ESCs, 11 out 
of the 13 imprinted genes that contain sufficient cover-
age show biallelic expression in both ESC lines (Fig. 2a; 
Additional file  6: Table  S5). Considering the pattern 
observed in the embryonic tissues, this strongly suggests 
that imprinted gene expression in fertilized ESCs is lost 
during outgrowth or maintenance of ESCs. In line, two 
out of three ESC-NT lines (ESC-NT2 and ESC-NT3) 
and all three ESC-PGA lines show biallelic expression for 
the majority of imprinted genes that contain sufficient 
coverage (11 out of 16 autosomal genes). In contrast to 
a previous study [47], we find monoallelic (imprinted) 
expression of Igf2r in the ESCs. This difference in allelic 
bias of Igf2r might be caused by a difference in mouse 
strains used, as we also find monoallelic expression of 
Igf2r in the B6D2F1 embryonic tissues (Fig. 2a). To gain 
further insight into the loss of imprinted gene expres-
sion, we performed allele-specific ChIP-Seq profiling of 
the posttranslational histone modifications H3K4me3 
and H3K27me3, epigenetic marks associated with gene 
activity or gene silencing, respectively [48]. In line with 
the biallelic expression of imprinted genes in ESCs, 
the imprinted monoallelic presence of H3K4me3 and 
H3K27me3 is largely lost in B6D2F1 fertilized ESCs, 
ESC-NTs or ESC-PGAs (Additional file  2: Fig. S11 and 
Fig. S12). Interestingly, one NT-derived ESC line (ESC-
NT1) showed an allelic bias of > 80% for most of the 
genes which were covered by the allele-specific RNA-seq 
(Snrpn/Snurf, D7Ertd715e, Rian, Meg3 and Igf2r), similar 
to the monoallelic expression observed in the embryonic 
tissues (Fig. 2a). This suggests that the loss of monoallelic 
expression of imprinted genes observed for ESC-NT2 
and ESC-NT3 is likely associated with the derivation and 
maintenance of the ESCs rather than with the nuclear 
transfer per se. Furthermore, this shows that occasion-
ally ESC lines (largely) retain imprinted gene expression, 
in line with previous observations on the variation of 
imprinted gene expression in ESCs [24].
To investigate whether the observed loss of imprinted 
gene expression was B6D2F1-strain specific, we ana-
lyzed allele-specific RNA-seq profiles from fertilized 
ESCs originating from a cross between mouse strains 
Mus musculus (M.m.) domesticus 129/SV-Jae (129) and 
M.m. castaneus (Cast) (129xCast) that we generated 
previously (Additional file  2: Fig. S13; ESC 129CastF1 
[42]). Similar to the B6D2F1 ESCs, almost all imprinted 
genes were biallelically expressed [< 80% allelic bias for 
12 out of 13 genes (92%)], showing that the observed 
loss of imprinting in ESCs is independent of the geno-
type. We next asked whether the loss of imprinted gene 
expression is dependent on culture conditions. The 
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B6D2F1 and 129CastF1 ESC lines are maintained in 
the presence of serum [either supplemented with LIF 
(129CastF1 ESCs) or on feeder cells (B6D2F1 ESCs)]. It 
has been shown that culturing ESCs in serum-free mini-
mal media containing 2 kinase inhibitors (“2i”) maintains 
or reverts ESCs toward the ground state of pluripotency, 
resulting in an ESC transcriptome resembling the early 
in  vivo tissue of the inner cell mass [49–52]. We there-
fore adapted the 129CastF1 ESCs to 2i media (> 12 days) 
and assayed imprinted genes by allele-specific RNA-seq. 
Adaptation to 2i did not result in major changes in the 
ratio of allelic expression of imprinted genes, and the 
majority of imprinted genes (17/19; 89%) still showed 
biallelic expression (Additional file  2: Fig. S13; ESC 
129CastF1_2i). These results show the strong tendency of 
ESCs to lose imprinted gene expression.
The observed biallelic expression of imprinted genes in 
ESCs is likely to be the consequence of (1) a loss of epi-
genetic imprints at the imprinted control regions (ICRs); 
and/or (2) a relaxation in the ESCs to “read” these epige-
netic imprints. Also, for some imprinted genes monoal-
lelic expression only arises during development [53]. To 
further investigate these issues, we differentiated ESCs to 
embryoid bodies (EBs) or neural progenitor cells (NPCs). 
EB differentiation of either 2i ESCs or serum ESCs did 
not change the biallelic expression of imprinted genes 
as observed in the undifferentiated ESCs (Fig. 2b; Addi-
tional file 2: Fig. S14). Most of the imprinted genes also 
remained biallelically expressed in the NPCs generated 
from the ESCs (Fig. 2b). Together, this shows that ESCs 
tend to lose imprinting and that imprints are not rein-
stalled upon differentiation of the ESCs toward develop-
mentally more advanced cell types.
Allele‑specific expression of imprinted genes in EpiSCs
In contrast to ESCs, fertilized EpiSCs and EpiSC-NTs 
largely retain allele-specific expression of imprinted 
genes as compared with the in  vivo embryonic tissues, 
including their in  vivo counterparts ERSE and APE 
(Fig. 2a). A total of 10 of the 15 genes that were imprinted 
or biased in the embryonic tissues show full imprinting 
in EpiSC and EpiSC-NT lines, while another two genes 
(Atp10a and H13) show a strong allelic bias. Addition-
ally, Peg12, Peg10 and Plagl1, for which we obtained 
insufficient coverage of the RNA-seq in the embryonic 
tissues, show imprinted gene expression in the ferti-
lized EpiSC and EpiSC-NT lines. Mcts2, Asb4 and Phf17 
lost imprinted gene expression in the fertilized EpiSCs 
and EpiSC-NTs as compared to the embryonic tissues 
(Fig.  2a). Notably, Rian and Meg3 (also known as Gtl2) 
have very high coverage in the fertilized EpiSCs and in 
EpiSC-NT2, but lack sufficient coverage of the RNA-seq 
to determine allelic bias in the EpiSC-NT1 and EpiSC-
NT3 (Fig. 2a; Additional file 6: Table S5). In line, expres-
sion of Rian and Meg3 is nearly absent in EpiSC-NT1 and 
EpiSC-NT3, in contrast to the high expression observed 
in the other EpiSC lines (Fig. 3a, b). This is reminiscent 
of the aberrant Rian and Meg3 silencing in iPSC lines, 
for which proper imprinting of both genes is essential to 
retain full developmental potential [16].
To study the effect of nuclear transfer at the total 
expression level of imprinted genes, we performed reg-
ular (non-allele specific) gene expression analysis of 
fertilized EpiSCs and EpiSC-NTs. Although only few 
imprinted genes were present among all differentially 
expressed genes (adjusted p value < 0.05; Additional file 7: 
Table  S6), the imprinted genes Igf2 and Cdkn1c (p57) 
were among the most significant (Additional file  2: Fig. 
S16; Additional file 7: Table S6). Imprinting of Igf2 is rela-
tively unstable [54] and loss of imprinting might there-
fore partly underlie the increased expression of Igf2 in 
the EpiSC-NT lines. However, Igf2 as well as Cdkn1c do 
not contain SNPs in the B6D2F1 genotype to confirm loss 
of imprinting in the current study. Functionally, Igf2 and 
Cdkn1c are important in control of cell proliferation and 
development [55]. As such, misregulation of these genes 
as observed in EpiSC-NT cells might provide a selective 
growth advantage, as previously suggested for Igf2 in 
human ESCs [54].
Calling of allele-specific bias on the B6D2F1 het-
erozygous part of the EpiSC-PGA genomes clearly 
shows a (near) complete loss of monoallelic expression 
of imprinted genes, in line with the absence of paternal 
imprinting (Fig.  2a). For known paternally expressed 
genes included in Fig. 2a, this resulted in an average drop 
in expression of > fourfold in the EpiSC-PGAs (Fig. 3b, c). 
Seven of the twelve paternal imprinted genes as shown in 
Fig. 2a show a significant change in expression (adjusted 
(See figure on next page.)
Fig. 3 Misexpression of imprinted genes in EpiSC-NTs and EpiSC-PGAs. a Example of tag-normalized RNA-seq data over imprinted genes in EpiSCs. 
A further extension of this example is shown in Additional file 2: Fig. S10. b Quantification of expression levels (RPKM) of the genes shown in Fig. 2a. 
The individual replicas of all samples are included in the graph, but not individually labeled. “P” = paternally expressed; “M” = maternally expressed. 
Additional file 2: Fig. S15 additionally includes quantification of expression levels of the B6D2F1 embryonic tissues. c Average fold change in gene 
expression in EpiSC-PGAs as compared to fertilized EpiSCs. Statistically significant changes (adjusted p value < 0.05) are indicated with a asterisk. A 
detailed genome browser view for Snrpn/Snurf and D7Ertd715e is shown in a. Besides imprinted genes included in Fig. 2a, this panel additionally 
includes all other known imprinted genes differentially expressed between EpiSCs and EpiSC-PGAs (Additional file 7: Table S6)
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p value < 0.05; Additional file 7: Table S6). The same trend 
was observed for other well-known paternally imprinted 
genes for which the B6D2F1 genotype does not have 
allelic coverage, such as Peg3 (Fig.  3c). In line, of all 77 
genes that are significantly downregulated in EpiSC-
PGAs as compared to fertilized EpiSCs (adjusted p value 
< 0.05), the top most downregulated genes are known 
imprinted genes (Additional file  7: Table  S6). In con-
trast to paternally expressed genes, maternally expressed 
genes generally showed a minor (but occasional signifi-
cant) upregulation in the EpiSC-PGAs. While no mater-
nally expressed genes were significantly downregulated, 
three were significantly upregulated (out of a total of 
47 upregulated genes (adjusted p value < 0.05) between 
EpiSC-PGAs and fertilized EpiSCs (Additional file  7: 
Table  S6; Fig.  3c). The observed ~ twofold increase is 
in agreement with the lack of a silent, imprinted pater-
nal allele in the EpiSC-PGAs. To gain further insight 
in the regulation of imprinted genes in EpiSC-PGAs, 
we performed global DNA methylation profiling using 
MethylCap-Seq. Analysis of the ICRs belonging to the 
imprinted genes in the EpiSC-PGAs showed (1) a loss of 
DNA methylation on the ICR for paternally imprinted 
(maternally expressed) genes; and (2) a twofold gain of 
DNA methylation on the ICR for maternally imprinted 
(paternally expressed) genes (Additional file 2: Fig. S17). 
Altogether, these results indicate that both alleles in the 
EpiSC-PGAs contain a maternal imprinting pattern, and 
therefore, imprinting in the EpiSC-PGAs is correctly 
maintained as both alleles are maternally derived. Inter-
estingly, these observations in EpiSC-PGAs are different 
from ESC-PGAs, which tend to show a loss of genomic 
DNA methylation imprints (Fig. 2a) [26].
X inactivation in EpiSC: EpiSC clonality
For most of the EpiSC lines, we noticed a full allelic bias 
in Xist expression associated with X inactivation (Fig. 2a). 
Random X inactivation (rXCI) occurs in the mouse 
between E5.5 and E7.5 during which individual female 
cells in the epiblast randomly inactivate one of the two 
X chromosomes, which is stably propagated to daughter 
cells [56]. Consequently, female founder cells of EpiSCs 
have usually undergone rXCI and EpiSC lines contain an 
active (Xa) as well as an inactive X chromosome (Xi) [57]. 
The noncoding RNA Xist is required for X inactivation 
and is specifically expressed from the Xi [58, 59]. Consid-
ering that B6- and DBA2-derived X chromosomes have 
an equal chance to be inactivated during rXCI [as both 
contain the same X-controlling element “b” locus  (Xceb)] 
[60], the ratio of female B6D2F1 cells within the epiblast 
that contain either an inactivated B6- or DBA2-derived 
X chromosome is around 0.5. Similarly, in case (some) 
founder cells initiate rXCI during derivation or early 
culturing of the EpiSC lines, the ratio is also around 0.5. 
Therefore, we expected that half of the cells within female 
EpiSC lines would contain an inactive B6-derived X chro-
mosome, while the other half of the cells would contain 
an inactive DBA2-derived one. At population level of 
stable EpiSC lines, this would be represented by an equal 
allelic expression of Xist from the B6- and DBA2-derived 
X chromosome. However, most of the EpiSC lines that 
we included in our analysis show a full allelic bias of Xist 
(Fig. 2a).
To further investigate the allelic bias of Xist, we 
examined expression of Xist and other X-linked genes. 
As expected, Xist is highly expressed in all six female 
EpiSC lines, but not in the seven female ESC lines as the 
female ESC founder cells have not yet undergone rXCI. 
Also, Xist expression is absent in the single male ESC 
and the two male EpiSC lines that were included in this 
study (Fig. 4a, b). Independent of their origin (fertilized 
EpiSC, EpiSC-NT or EpiSC-PGA), five of the six female 
EpiSC lines showed full bias in allelic expression of Xist, 
with expression from the B6-derived X chromosome 
Fig. 4 Completely skewed X inactivation in B6D2F1 EpiSCs. a Tag-normalized RNA-seq data over Xist gene. b Quantification of Xist expression 
(RPKM), including allelic bias for the EpiSCs. Expression of Xist in the ESCs is too low to quantify allelic bias. c Distribution of relative expression 
of genes from the B6 versus the DBA2 allele in the ESC and EpiSC lines over chromosome X or autosomes (control). A log2 ratio of 0 represents 
equal gene expression from the B6 and DBA2 alleles, while positive and negative ratios represent higher expression from the B6 or DBA2 allele, 
respectively. On top the number of genes included in each of the boxplots, for the PGA lines we only included genes in the heterozygous B6/
DBA2 parts. Besides ESC-NT1, EpiSC2 and EpiSC3, all lines are female. Note that the EpiSC-PGAs contain a largely heterozygous X chromosome 
including the Xist locus, enabling allele-specific RNA-seq calls (Additional file 4: Table S3). d B6/DBA2 ratio per gene over the linear X chromosome 
(the X-axis represents genomic coordinates in MB). Each dot represents a gene, and 50 genes had sufficient coverage over SNPs to be included. In 
blue (for female EpiSC1 and EpiSC-NT1) the B6/DBA2 ratio obtained by DNA sequencing at 5 MB resolution, confirming the presence of a B6 and 
DBA chromosome X in both lines. Additional file 2: Fig. S18 includes the same graphs for all B6D2F1 fertilized and NT ESCs or EpiSCs included in 
this study. e Distribution of gene expression in ESC and EpiSC lines over chromosome X or autosomes (control). The lower expression of X-linked 
genes in EpiSCs as compared to ESCs is the consequence of XCI in the EpiSCs resulting in dosage compensation between expression of autosomes 
and chromosome X. Genes with an expression level of RPKM > 2 in all ESC (246 and 8416 genes on chromosome X and autosomes, respectively) or 
EpiSC lines (332 and 9382 genes on chromosome X and autosomes, respectively) are included in this analysis
(See figure on next page.)
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being observed in most of the EpiSC lines (Fig.  4b). In 
line with the allelic bias of Xist in these five EpiSC lines, 
we observed a (near) monoallelic expression of the far 
majority of X-linked genes reciprocal to the allelic ratio 
of Xist (Fig.  4c, d). EpiSC-NT3 is the only line which 
showed equal expression of X-linked genes from both 
B6 and DBA2 alleles (Fig. 4c, d), including Xist (Fig. 4b). 
We observed biallelic expression and an increased global 
expression of X-linked genes in the female ESC lines 
(except for ESC-NT2), in keeping with the presence of 
two active X chromosomes in ESCs (Fig. 4c, e; Additional 
file  2: Fig. S18a). ESC-NT1 is male and, therefore, only 
shows B6-derived RNA-seq signals from the X chromo-
some (Fig. 4c; Additional file 2: Fig. S18a). As female ESCs 
are prone to the loss of one X chromosome, we analyzed 
the  karyotype of the ESC lines as a control (Additional 
file 1: Table S1; [61]). This showed that the ESC-NT2 line 
is largely X0, explaining the allelic bias and the reduc-
tion in X-linked gene expression for ESC-NT2 (Fig. 4c, e; 
Additional file 2: Fig. S18a). Together, our results indicate 
that 5 of the 6 female EpiSC lines show a complete skew-
ing of XCI, with the DBA2-derived X chromosome being 
active (Xa) in 4 EpiSC lines and the B6-derived X chro-
mosome being active (Xa) in the EpiSC-PGA2 line. The 
most likely explanation for the observed skewing is that 
the EpiSC lines are (largely) of clonal origin, as further 
outlined in the discussion. Only occasionally, EpiSC lines 
are derived from a mixed population of cells, as is the 
case for the EpiSC-NT3 line which consists of a mixed 
population of cells containing either an inactive B6- or an 
inactive DBA2-derived X chromosome. Since derivation 
of the EpiSCs was performed using standard protocols [1, 
25, 62], clonality is likely to be a common phenomenon 
among EpiSC lines.
Discussion
Genomic imprinting is critical for proper development, 
as alterations in imprinting gene dosage in early embryos 
are often associated with development defects (reviewed 
by Peters [63]). In line, we demonstrate that parent-spe-
cific monoallelic expression of imprinted genes is intact 
in pre- and post-implantation embryos. Within in  vitro 
cultures, maintenance of imprinted gene expression in 
embryonic cells is essential to retain full developmental 
potential [13–16]. Considering this critical role, previ-
ous studies have assayed allelic bias of imprinted gene 
expression in fertilized ESCs and EpiSCs [24, 54, 64, 65]. 
However, most of these studies were performed on a 
restricted panel of imprinted genes by targeted sequenc-
ing of expressed SNPs in cDNA. In case of NT and PGA, 
allelic bias of imprinted genes in mouse ESCs or EpiSCs 
has mainly been assayed by non-allele-specific DNA 
methylation profiling, either at a genome-wide scale or 
using more targeted approaches [25, 26, 66–68]. Infor-
mation on allele-specific expression of imprinted genes 
in NT and PGA lines is largely absent. Importantly, 
most of the studies investigating imprinting in ESCs and 
EpiSCs did not include analysis of the embryonic tis-
sues and therefore cannot discriminate between lack of 
imprinting in embryonic tissue versus loss (or gain) of 
imprinting during derivation of ESCs and/or EpiSCs. The 
analysis performed here therefore extends previous stud-
ies by providing a comprehensive overview of imprinted 
gene expression in pluripotency. The use of isogenic tis-
sues and cell lines in the current study allows for direct 
comparisons between pluripotent cells and as such pro-
vides a benchmark to allow identification of cell lines that 
faithfully maintain imprinted gene expression. A notable 
example showing the power of the dataset we generated 
represents the known imprinted gene Ube3a, for which 
the biallelic expression observed in the ESC and EpiSC 
lines is not due to a loss of imprinting, but due to absence 
of imprinting in the embryonic tissue of origin. It should 
be noted that the B6D2F1 hybrid mouse strain which we 
used for our analysis contains relatively few polymorphic 
sites (~ 5.2 million) as compared to other hybrid mouse 
crosses that are often used to study allelic gene expres-
sion (e.g., a 129xCast hybrid mouse strain contains ~ 20.8 
million polymorphic sites [42]). Therefore, the coverage 
over imprinted genes to be included in our analysis is 
relatively low. However, the B6D2F1 genotype has been 
shown to be superior over other mouse strains in nuclear 
transfer and PGA (both in efficiency and in the devel-
opment and quality of the embryos or pluripotent cell 
lines [31, 33, 69, 70]), which we used as main criteria for 
selecting the B6D2F1 strain for the current study.
To facilitate global allele-specific expression analy-
sis of PGA-derived cell lines, we performed RNA-seq-
based genotyping to determine the positions of genomic 
crossover. A direct comparison with regular DNA geno-
typing shows that the algorithm is robust and accurate 
in detecting chromosomal breakpoints. Despite the fact 
our RNA-seq genotyping method lacks resolution in 
“gene deserts” because of the absence of coverage of the 
RNA-seq, the position of the genomic breakpoints called 
from the RNA-seq exactly matches the DNA-based geno-
typing in over half of the cases. Previous studies report-
ing chromosomal breakpoints in human or mouse PGA 
p(MII)ESC lines used either (1) DNA genotyping of 
p(MII)ESCs derived from an F1 mouse cross similar to 
the DNA genotyping performed here used as a control 
(Additional file 2: Fig. S6) [10]; (2) the signature of hete-
rozygous and homozygous signals over SNPs as obtained 
by DNA-based genotyping [41] or by RNA-seq [71]. The 
latter method takes advantage of the fact that p(MII)
ES cells retain pericentromeric homozygosity but show 
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distal regions of heterozygosity due to crossing-over in 
the oocyte [10, 41] and is particularly powerful if paren-
tal genotypes are unknown. However, in the absence 
of parental genotypes, this method cannot discrimi-
nate between homozygotic parts of the genome being 
derived from either the paternal or the maternal parent 
of the oocyte donor. By taking advantage of mouse inbred 
strains and the known genomes of the B6 and DBA2 
mouse strains, our method enables accurate characteriza-
tion of the genotype of the PGA-derived ESC and EpiSC 
lines. This allowed us to comprehensively show for the 
first time that twofold upregulation of known maternally 
expressed genes in PGA-derived cells is caused by the 
activation of the paternal allele (which lacks the imprint 
in the PGA lines), as these genes show an equal biallelic 
expression in our allele-specific analysis. Next to its use 
for PGA lines, our RNA-seq-based genotyping method 
is applicable to F2 hybrids and subsequent generations 
of crossbreeds, as well as backcrosses, of (mouse) inbred 
strains. As such, genotypic information can conveniently 
be obtained for studies where gene expression analysis by 
RNA-seq has been performed.
Our genome-wide study shows that mouse ESCs tend 
to lose imprinting, while EpiSCs retain their imprints, 
similar to previous observations on a restricted panel of 
imprinted genes [24]. In contrast to fertilized EpiSCs, 
EpiSCs derived after NT were reported to show aber-
rant expression of a large number of imprinted genes 
[25]. However, this conclusion was largely based on 
analyses of EpiSC lines that accidentally originated from 
parthenogenesis (instead of NT), which indeed show 
loss of imprinted gene expression (Fig. 2a). Our current 
analyses, including proper genotyping as control for the 
nuclear transfer, show that allelic expression of imprinted 
genes is largely retained in EpiSC-NTs (Figs. 2, 3). Despite 
the similarity of EpiSC-NT lines to embryonic tissues or 
fertilized EpiSCs, the Dlk1-Dio3 imprinted gene cluster is 
notably different in expression. In this cluster, Rian and 
Meg3 are robustly expressed in the fertilized EpiSC lines 
and one EpiSC-NT line, while expression is absent in two 
EpiSC-NT lines. Aberrant silencing of Rian and Meg3 
has previously been observed in iPSC lines. In contrast 
to iPSC lines with normal expression of Rian and Meg3, 
iPSC lines in which these genes are silenced contribute 
poorly to chimaeric mice and fail to support the develop-
ment of entirely iPSC-derived mice [16]. The misexpres-
sion in the Dlk1-Dio3 imprinted gene cluster has been 
associated with transcription factor-mediated repro-
gramming, as it has not been observed in other methods 
of reprogramming thus far. Although we only profiled a 
small sample set, our data suggest that silencing of Rian 
and Meg3 is a more general phenomenon in reprogram-
ming and can also occur during nuclear transfer. In 
iPSCs, the presence of ascorbic acid during reprogram-
ming prevents misexpression of the Dlk1-Dio3 cluster 
[72]. It will be interesting to test whether the presence 
of ascorbic acid after nuclear transfer can similarly pre-
serve a normal imprinting status at the Dlk1-Dio3 gene 
cluster in EpiSC-NTs. If so, this might underlie the ben-
eficial effect of ascorbic acid on mouse nuclear transfer as 
reported recently [73].
EpiSCs are derived during in vitro outgrowth of post-
implantation epiblasts on which colonies emerge. In 
order to obtain pure EpiSCs and get rid of the remainder 
of the mouse epiblast outgrowth, these EpiSC colonies 
are picked after a week of epiblast culture to be further 
expanded toward EpiSC lines [1, 25, 62]. It has been 
observed that the EpiSCs colonies emerging from the 
epiblast are generally localized close together [25] (Alice 
Jouneau, personal communication). The close concentra-
tion of EpiSC colonies might suggest a clonal origin of 
EpiSC lines. rXCI randomly occurs in early post-implan-
tation female embryos (generally before collection of the 
epiblast for EpiSC derivation) and is stably maintained 
afterward. Therefore, full skewing of XCI is widely used 
to assess clonality [74]. The use of mouse F1 hybrid in 
combination with allele-specific RNA-seq allows for 
convenient detection of skewing, which otherwise often 
remains unnoticed. Our analysis shows that five of the 
six female EpiSC lines as profiled here show a complete 
skewing of XCI (Fig. 4). Therefore, this strongly suggests 
that these EpiSC lines are clonal, although we cannot 
exclude that the EpiSC lines originate from two or more 
founder cells that inactivated the same copy of the X 
chromosome. In line, the EpiSC colonies emerging from 
the epiblast during derivation of the EpiSC-NT3 line 
(which showed biallelic expression of Xist) were spread 
over a much larger area of the epiblast, explaining the 
EpiSC-NT3 line not being clonal. Altogether, the skewed 
XCI observed for the majority of EpiSC lines included in 
the current study suggests that these lines originate from 
a single cell of the early epiblast that divided further dur-
ing development and gave rise to multiple colonies dur-
ing in  vitro outgrowth, which were picked for further 
expansion. The discrete areas showing outgrowth of 
EpiSC colonies might reflect regions of the epiblast that 
are more permissive toward EpiSC derivation than other 
areas. This could be due to the heterogeneous nature of 
the epiblast, which contains a range of cells with differ-
ent commitment toward the various embryonic lineages 
[75], and of which only a few cells might be susceptible 
for outgrowth toward EpiSC lines.
Collectively our observations yield insight into global 
imprinted gene expression patterns during early embry-
onic development, and the cell lines derived from these 
early embryonic stages. Thereby, it provides a benchmark 
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to allow identification of cell lines that faithfully maintain 
imprinted gene expression and therefore retain full devel-
opmental potential. Our study provides further evidence 
that, in contrast to EpiSCs, ESCs are prone to lose allelic 
expression of imprinted genes. It should be noted that 
the majority of ES cell lines included in this study were 
female, which are more susceptible to losing imprinting 
as compared to male ESCs due to their hypomethylated 
state [76]. Also, it has been shown that prolonged in vitro 
culture of ESCs in serum containing media perturbs the 
maintenance of methylation imprints that control the 
allelic expression of imprinted genes [20–23], which for 
the ESC lines included in this study largely occurred 
within 20–30  days (8–14 passages; Additional file  1: 
Table S1). EpiSC lines as included in this study were cul-
tured in serum-free medium (CDM [77]), which might 
facilitate the maintenance of imprinting in EpiSCs, for 
both male and female EpiSCs (Additional file 1: Table S1). 
In recent years, the use of kinase inhibitors (“2i”) within 
a serum-free defined medium has enabled derivation of 
mouse ground state pluripotent ESCs that more faithfully 
reflect early in  vivo cells of the inner cell mass as com-
pared to conventional ESCs cultures in serum and LIF 
[49–52, 78]. Despite the fact that adaptation of conven-
tional ESCs to 2i allows for reprogramming of the epig-
enome to the ground state [50, 79, 80], it does not rescue 
the imprinting pattern of founder embryonic cells (Addi-
tional file  2: Fig. S13). This is in line with very recent 
studies showing that the use of 2i-conditions results in 
erosion of DNA methylation at most ICRs in ESCs [39, 
40]. Importantly, we show that the allelic expression of 
imprinted genes is not restored upon differentiation 
of the ESCs, while also conversion of ESCs to EpiSCs 
does not restore imprinting patterns [24]. Together, this 
strongly suggests that the loss of imprinted gene expres-
sion as observed in ESCs is caused by an irreversible loss 
of epigenetic imprints (i.e., a loss of DNA methylation (or 
other epigenetic marks [81]) at ICRs), rather than a relax-
ation in ESCs to translate these imprints to monoallelic 
expression.
Based on a wide variety of features (including tran-
scriptome, epigenome and signaling responses), con-
ventional human ESCs are considered to be the human 
equivalent of mouse EpiSCs [1, 4, 82]. In line, imprinting 
in human ESCs has been considered to be relatively sta-
ble. Recently, various groups have reported the derivation 
of human ESCs in a naive state akin to mouse ESCs [83–
87]. The DNA hypomethylation reported at ICRs in these 
naive human ESCs suggests that monoallelic expression 
of imprinted genes is lost, similar to mouse ESCs [88, 89]. 
However, only few ICRs are well documented, and it has 
been shown that imprinting can rely on other epigenetic 
features besides DNA methylation [27, 81, 90]. Therefore, 
global analysis of imprinted genes by allele-specific RNA-
seq in naive human ESCs will be highly informative to 
further evaluate loss of imprinted gene expression. Also, 
such profiling will be helpful in the future to further eval-
uate optimized culture conditions for naive mouse and 
human ESCs.
Conclusions
In the current study, we performed allele-specific RNA-
seq of early (extra-)embryonic tissues and various types 
of pluripotent cell lines in vitro using an isogenic mouse 
F1 genotype, allowing genome-wide comparative analy-
sis of imprinting. This shows that mouse ESCs tend to 
lose imprinting during outgrowth, while EpiSCs largely 
retain imprints, even if they are derived from nuclear 
transfer embryos. Profiling of EpiSC-PGAs shows that 
known maternally imprinted (paternally expressed) genes 
are silent, while known paternally imprinted (mater-
nally expressed) genes consistently have a twofold higher 
expression level in EpiSC-PGAs as compared to their fer-
tilized counterparts. The upregulation of known mater-
nally expressed genes in the EpiSC-PGAs is caused by 
the absence of the imprinted, silent paternal allele in 
the EpiSC-PGAs, as these genes show an equal biallelic 
expression in our allele-specific analysis. Differentiation 
of ESCs, as well as reversion of ESCs to the pluripotent 
ground state, does not restore monoallelic expression 
of imprinted genes, strongly suggesting that the loss of 
imprinting in ESCs is irreversible. This has important 
implications for the use of these cells in further applica-
tions, as correct imprinting is critical to retain full devel-
opmental potential. Together, our analysis provides a 
comprehensive overview of imprinted gene expression in 
pluripotency and provides a benchmark to allow identi-
fication of pluripotent cell lines that faithfully maintain 
imprinted gene expression.
Methods
Cell culture
Derivation and maintenance of B6D2F1 ESC and EpiSC 
lines is described in Kobolak et  al. [91] and Maruotti 
et  al. [25], respectively. B6D2F1 ESCs were cultured on 
mouse embryonic fibroblast (MEF) feeder cells in media 
containing fetal calf serum (FCS). B6D2F1 EpiSCs were 
maintained feeder-free in chemically defined medium 
(CDM; [77]) complemented with 20  ng/ml activin A 
and 12  ng/ml fibroblast growth factor 2 (FGF2), in the 
absence of fetal bovine serum. In order to get rid of the 
MEFs for RNA-seq or ChIP-Seq, ESCs were replated on 
6  cm feeder-free culture dishes and incubated at 37  °C. 
After 30 min, floating ESCs were harvested, washed with 
PBS and collected. An extensive overview of the cell 
lines used in this study, including sex, passage number, 
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karyotyping, genotype information and names as use 
previous studies (if the cell lines were derived before) is 
present in Additional file  1: Table  S1. None of the ESC 
or EpiSC cell lines have tested for their capacity to form 
teratomas, for their contribution toward chimaeric mice 
or for their capacity to form completely ES cell-derived 
fetuses (/germline transmission).
Embryo sample preparation and RNA‑seq
The embryo sample preparation and RNA-seq has been 
described previously [28]. In short, for preimplantation 
B6D2F1 mouse embryonic tissues, samples were col-
lected by flushing embryos out of the uterus. For isola-
tion of the E3.5 inner cell mass (ICM) of the expanded 
blastocyst (Expanded Blastocyst: Inner cell mass; “EBI”), 
ICMs were isolated from E3.5 B6D2F1 blastocysts by 
immunosurgery [92]. After removal of the zona pellucida 
by incubation in acid Tyrode’s solution (Sigma-Aldrich), 
blastocysts were collected in KSOM (potassium-sup-
plemented simplex optimized medium) containing 20% 
anti-mouse serum (Sigma-Aldrich) for 30  min at 37  °C. 
After 3 times washing in KSOM, blastocysts were incu-
bated for 5–10  min in guinea pig complement (Calbi-
ochem-Merck) diluted 1:10 with KSOM. After serial 
washings, the embryos were cultured for 30–60  min in 
KSOM. Finally, the ICMs were pipetted through a thin 
micropipette in order to mechanically remove the lysed 
trophectoderm cells. For isolation of E3.5 mural trophec-
toderm (Expanded Blastocyst: mural TrophEctoderm; 
“EB-TE”), laser-assisted (XY Clone, Hamilton Thorne, 
UK) ICM isolation was performed on intact, expanded 
E3.5 blastocysts as previously described [93]. The 
embryos were secured by two holding pipettes with the 
ICM being positioned at 9 o’clock. Once adequate ten-
sion was established, several (about 10–15) infrared laser 
pulses (300mW, 1 ms) were fired to section the blastocyst 
into two uneven portions, of which one consisted of the 
mural trophectoderm cells.
Tissues from post-implantation stages were obtained as 
in Brons et al. [1]. Briefly, pregnant female animals were 
euthanized by cervical dislocation. After surgical removal 
of the uterine horns, decidua was removed using sharp 
fine edge forceps. After removing the embryo from the 
decidua, the Reichert’s membrane was torn out from 
the embryo and the ectoplacental cone trophoblast tis-
sue was sliced out. The visceral endoderm was removed 
from the embryo after incubation in cell dissociation 
buffer (Invitrogen). At E6.25, radially symmetrical epi-
blast was dissected from the extra-embryonic ectoderm 
and collected as clean epiblast (Epithelial Radially Sym-
metrical Epiblast; “ERSE”). At E7.25, the anterior–poste-
rior epiblast was collected with its attached mesodermal 
wings (Anterior–Posterior Epiblast; “APE”) but without 
any extraembryonic mesoderm tissues. Samples were 
harvested into TriZol and snap-frozen. RNA was iso-
lated using the PureLink™ RNA Micro Kit (Invitrogen). 
100 pg RNA of the embryo samples was used to prepare 
cDNA according to the SMARTer (Clontech) method 
and sequenced paired-end on Illumina Hi-Seq 2000. All 
RNA-seq of the embryonic tissue samples (FASTQ and 
BedGraph or wig files) are present in the NCBI GEO 
SuperSeries GSE53387. An overview of this data is pre-
sent in Additional file 1: Table S1.
RNA isolation and cDNA synthesis of ESCs and EpiSCs
RNA was harvested (1) for the ESCs using the RNeasy 
Plus Mini Kit (QIAGEN) including gDNA eliminator 
treatment according to instructions of the manufacturer; 
and (2) for the EpiSCs using TriZol (Invitrogen) accord-
ing to the manufacturer’s recommendations. Total RNA 
(100  μg) was subjected to two rounds of poly(A) selec-
tion (Oligotex mRNA Mini Kit; QIAGEN), followed 
by DNaseI treatment (QIAGEN). mRNA (100–200  ng) 
was fragmented by hydrolysis (5 × fragmentation buffer: 
200 mM Tris acetate, pH8.2, 500 mM potassium acetate 
and 150  mM magnesium acetate) at 94  °C for 90  s and 
purified (RNAeasy Minelute Kit; QIAGEN). cDNA was 
synthesized using 5 μg random hexamers by Superscript 
III Reverse Transcriptase (Invitrogen). Double-stranded 
cDNA synthesis was performed in second strand buffer 
(Invitrogen) according to the manufacturer’s recommen-
dations and purified (Minelute Reaction Cleanup Kit; 
QIAGEN).
RNA‑seq, ChIP‑seq and MethylCap‑seq of ESCs and EpiSCs
ChIP-Seq was performed according to Marks et al. [50], 
MethylCap-Seq was performed according to Veillard et al. 
[94]. For RNA-seq, cDNA was prepared for sequencing 
either by (1) end repair of 20 ng double-stranded cDNA 
as measured by Qubit (Invitrogen), ligation of adaptors to 
DNA fragments followed by size selection (~ 300 bp) and 
PCR amplification; or by (2) using the Kapa Hyper Prep 
kit (KAPA Biosystems) according to manufacturer’s pro-
tocol, followed by PCR amplification and size selection. 
Quality control of the adaptor-containing DNA librar-
ies was performed by quantitative PCR and by running 
the products on an Automated Electrophoresis System 
[Experion (BioRad) or Bioanalyzer (Agilent)]. Cluster 
generation and sequencing was performed using the Illu-
mina Genome Analyzer IIx, Hi-Seq 2000 or NextSeq 500 
platforms according to standard Illumina protocols. 
Generation of FASTQ files and demultiplexing was per-
formed using Illumina CASAVA. All sequencing analyses 
were conducted based on the M. musculus NCBI m37 
genome assembly (MM9; assembly July 2007). Addi-
tional file 1: Table S1 summarizes the sequencing output. 
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All RNA-seq data and ChIP-Seq data (FASTQ and WIG 
files) are present in the NCBI Gene Expression Omnibus 
(GEO) SuperSeries GSE101292. An overview of these 
profiles is present in Additional file 1: Table S1.
Allele‑specific mapping using polymorphic sites 
between the B6 and DBA2 genomes
Known polymorphic sites between the Mus musculus 
domesticus mouse strains B6 and DBA2 [37] (nucleotide 
substitutions, not indels) were collected using polymor-
phic sites determined by (1) the Sanger mouse sequenc-
ing project using the March 2011 release using the 
strains C57BL and DBA [35, 36]; and (2) the NIEHS/
Perlegen mouse resequencing project [34] (we used the 
b04_Chr*_genotype.dat files for the species C57BL/6J 
(reference genome) and DBA/2J). This resulted in a total 
of 5,233,965 polymorphic sites between the genomes of 
B6 and DBA2. FASTQ files were mapped using GSNAP 
version 2012-07-20 [95]. To avoid bias in the mapping of 
either the B6- or the DBA2-derived reads, the alternative 
alleles of polymorphic sites between the B6 and DBA2 
genome were included in the reference during mapping 
(GSNAP SNP-tolerant mapping; flag—v). Only sequence 
tags aligning to a single position in the genome were 
included for further analysis. Within the individual sam-
ples, we used the mapped tags to determine the coverage 
per allele for each of the polymorphic sites using GSNAP 
tally. Per single polymorphic nucleotide, the pile-ups 
were subsequently assigned to either the B6 or the DBA2 
allele using custom Perl-based scripts. Polymorphic sites 
and analysis for the 129xCast ESCs (Fig.  2b, Additional 
file  2: Figs. S13 and S14) are described in Marks et  al. 
[42]. Profiles used for the 129xCast ESC analysis were 
obtained from NCBI GEO SuperSeries GSE60738 [42].
RNA‑seq genotyping
RNA-seq genotyping was performed by determining the 
percentage of B6 for the sum of B6 or DBA2 allelic counts 
over all polymorphic sites (B6/(B6 + DBA2) × 100%) 
in 5  MB or 1  MB chromosomal bins. At 5  MB resolu-
tion, we subsequently applied a moving average over 
four bins for the allelic ratios of bins that contained > 40 
counts over polymorphic sites summed for both alleles. 
Bins containing ≤ 40 SNP counts over polymorphic sites 
summed for both alleles were labeled “insufficient cover-
age.” 5 MB bins showing a B6 contribution between 0 and 
31% were labeled “DBA2” (paternal; yellow), between 31 
and 78.5% “B6/DBA2” (heterozygous; blue) and between 
78.5 and 100% “B6” (maternal; red), unless specified oth-
erwise. For the analysis at 1 MB resolution, bins contain-
ing > 10 (RNA sequencing) or > 15 (DNA sequencing) 
counts over polymorphic sites summed for both alleles 
were included in the analysis. To enable reliable calling of 
crossover breakpoints, we increased resolution and strin-
gency: 1 MB bins showing a B6 contribution between 0 
and 15% were considered DBA2, between 15 and 85% 
B6/DBA2 heterozygous and between 85 and 100% B6. 
The genotype at the start of the chromosome proximal 
to the centromere was assigned B6 or DBA2 if (1) ≥ 80% 
of 5 bins or (2) ≥ 60% of 10 bins were labeled as either 
DBA2 or B6; or heterozygous if > 5 consecutive bins were 
labeled heterozygous. Having characterized the genotype 
at the proximal part of the centromere, we applied a slid-
ing window approach toward the distal part of the chro-
mosome to estimate crossing-over breakpoints. These 
breakpoints were identified at positions after which > 5 
consecutive bins lacked the label of the assigned geno-
type (or ≥ 4 consecutive bins of the same genotype at the 
very proximal end of the chromosome). The genotype 
present after the breakpoints was determined by applying 
the same 3 criteria as at the start of the chromosome, or 
by the ≥ 4 consecutive bins of the same genotype at the 
proximal end of the chromosome. Breakpoints within 
15  MB were discarded if the genotype of the genomic 
regions neighboring the ≤ 15  MB region was same. The 
methods as described in this section were also applied for 
genotyping of the EpiSCs using genomic DNA (obtained 
from MethylCap-seq experiments present in NCBI GEO 
SuperSeries GSE47793) [94].
Gene expression analysis
In light of the difference in sequencing length between 
the samples (Additional file 1: Table S1), we only included 
the first 35 bp of the forward read for RPKM quantifica-
tion, data visualization and PCA/clustering analysis. (In 
case of paired-end reads, we only included the forward 
read if the distance between read pairs was < 10  kb to 
exclude aspecifically mapped reads but to include reads 
covering introns.) To obtain RNA-seq gene expres-
sion values (RPKM), we converted the GSNAP output 
to Browser Extensible Data (BED) files which were used 
as input for Genomatix (ElDorado 08–2011) select-
ing RefSeq genes (NCBI m37 genome assembly; MM9; 
Additional file  8: Table  S7). For viewing, profiles were 
normalized based on the total number of reads and con-
verted to Wiggle (WIG) files. Differential gene expression 
was called using DE-Seq 2 applying a Wald test and para-
metric fitting to estimate dispersion, followed by multiple 
testing correction using the Benjamini–Hochberg proce-
dure (“adjusted p value”), requiring a change > 1.5 fold.
Calling of allele‑specific gene bias
Counts over polymorphic sites within exons of individ-
ual RefSeq genes for either B6 or DBA2 were summed 
to obtain allele-specific gene expression counts for both 
species (Additional file  8: Table  S7). The ratio between 
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the B6 counts or the DBA2 counts versus the total counts 
(B6 + DBA2) represent the relative contribution of the B6 
or DBA2 allele, respectively, to expression of a particular 
gene. Alternatively, we used the ratio of all allelic counts 
within genes (log2 B6/DBA2). For analysis of imprinted 
genes in the various RNA-seq samples, we included 
genes that (1) contained a coverage of > 9 counts over the 
polymorphic sites present in the gene; and (2) showed a 
standard error of the mean (STDEM) of ≤ 0.15 over indi-
vidual polymorphic sites within a gene (these sites were 
required to contain a coverage ≥ 3 from either the B6 or 
DBA2 allele to be included; only applicable if multiple of 
such polymorphic sites were present). For inclusion in 
the global allele-specific analysis, we required that indi-
vidual genes contained coverage over polymorphic sites 
in each individual ESC, EpiSC or embryonic sample, 
with a total coverage over polymorphic sites of > 40 for 
all ESCs or EpiSCs samples and > 200 for all embryonic 
samples. Allelic bias was defined as > 80% contribution in 
expression from one allele. Genes showing < 80% allelic 
bias were considered to be biallelically expressed. For 
analysis of XCI, we included genes showing a < fourfold 
allelic bias between B6 and DBA2 in the EpiSC-NT3 line.
Analysis of epigenetic profiling
ChIP-Seq enriched regions (“peaks”) were determined 
on tag-normalized BED files using MACS version 1.4.2 
at p value  10−6 for H3K4me3 [96] or, for H3K27me3, 
using a minimum threshold of 24 overlapping tags, merg-
ing enriched regions within 1500 bp. Peak sets of either 
H3K4me3 or H3K27me3 were merged for all samples and 
quantified using the tag-normalized BED files by deter-
mining the number of reads present within the enriched 
regions for each of the profiles. Peaks were associated 
with the closest genes using Pinkthing [97]. For allele-
specific quantification of ChIP-Seq peaks, we summed 
the B6 or BDA2 counts over polymorphic sites within 
the peaks to calculate the contribution from each allele, 
similar to the method applied to calculate allelic ratios of 
gene expression from RNA-seq (see previous sections). 
Analysis of MethylCap-Seq was performed according to 
Veillard et al. [94].
Additional files
Additional file 1: Table S1. Overview of the B6D2F1 samples profiled 
in this study including information on passage number of the cell line, 
genotyping and allele-specific RNA-Seq and ChIP-Seq.
Additional file 2: Figure S1. Validation of the samples included in the 
current study using regular (non-allele specific) expression analysis of the 
RNA-Seq. Together with Additional file 2: Fig. S2, this data confirms the 
developmental stages of the samples. Top panel: Tag-normalized RNA-Seq 
data over known marker genes for the various pluripotent stages in a 
genome browser view. Bottom panel: Quantification of expression 
(RPKM) of the genes present in the genome browser view. The core 
pluripotency factors are abundantly expressed in most samples, and 
are higher in the ESCs as compared to the EpiSCs as expected. Known 
ESC specific factors are highly expressed in ESCs and EBI samples, but 
largely absent in EpiSCs and ERSE/ APE. Expression of EpiSC-specific 
markers is largely restricted to EpiSC and ERSE/ APE. Trophectoderm 
markers are mainly present in the EB-TE samples. Figure S2. Validation 
of developmental stage by principle component analysis (PCA) or 
clustering using global quantile normalized RPKM expression values 
(log2). We included genes showing a total RPKM >2 in ESCs and EpiSCs 
(16,059 genes out of 21,345 RefSeq genes). (a) PCA analysis showing a 
clear separation of samples along the first two principle components. 
The first principle component (PC; x-axis), explaining 26% of the total 
variation separates the in vivo versus the in vitro samples. This PC also 
includes the variation introduced during the library preparation of the 
RNA-Seq, as the in vivo samples are prepared by the low-input 
polyA-based SMARTer RNA-Seq method containing an amplification 
step while the ESC and EpiSC samples are prepared by regular 
polyA-selected RNA-Seq. The second principle component (y-axis), 
explaining 19% of the variation, mainly separates early from late 
embryonic stages for both the in vivo and in vitro samples. (b) Heatmap 
of correlation (Pearson’s r) including clustering using Euclidean distance 
showing a clear separation of the various cell types. Figure S3. 
Genotype of ESC lines as determined by RNA-Seq genotyping at 5MB 
resolution. The horizontal axis represents chromosomes, the vertical 
axis chromosomal bins (per 5 MB). The numbers within each bin (also 
categorized by the three colors) represent the percentage B6 as 
compared to the total coverage of B6 and DBA2 over the SNPs in each 
bin. The ESC lines are female unless indicated otherwise. X0: female 
ESCs with only a single X chromosome. Figure S4. Genotype of the 
embryonic tissues included in the current study as determined by 
RNA-Seq genotyping at 5MB resolution. See legend Additional file 2: 
Fig. S3 for further details. Figure S5. Genotype of EpiSC lines as 
determined by RNA-Seq genotyping at 5MB resolution. See legend 
Additional file 2: Fig. S3 for further details. The EpiSC lines are female 
unless indicated otherwise. The allelic bias observed for the X 
chromosome in EpiSC1, EpiSC-NT1 and EpiSC-NT2 is further discussed 
in Fig. 4 and the corresponding main text. Figure S6. Genotype of the 
EpiSC lines EpiSC-PGA1, EpiSC-PGA2 and EpiSC-NT1 based on genomic 
sequencing at 5MB resolution. See legend Additional file 2: Fig. S3 for 
further details. Figure S7. Validation of the RNA-Seq genotyping of the 
EpiSC-PGAs. Distribution of relative expression from the B6 versus the 
DBA2 allele of the genes present within genomic regions genotyped as 
either homozygous B6 (red), heterozygous B6/DBA2 (blue) or 
homozygous DBA2 (yellow) in the EpiSC-PGAs. A log2 ratio of 0 
represents equal biallelic gene expression from the B6 and DBA2 alleles, 
while positive and negative ratios represent higher expression from the 
B6 or DBA2 allele, respectively. Genes present in the part of the 
genome genotyped as heterozygous are largely expressed from both 
alleles, while alleles of genes present in the homozygous part of the 
genome cannot be discriminated (and therefore these genes show a 
(near) complete bias according to their genotype). Figure S8. 
Genotype of EpiSC2 line as determined by regular genotyping or 
RNA-Seq based genotyping at 5MB resolution. The horizontal axis 
represents chromosomes, the vertical axis chromosomal bins (per 5 
MB). The numbers within each bin (also categorized by five colors) 
represent the percentage B6 as compared to the total coverage of B6 
and DBA2 over the SNPs. The allelic bias as obtained for chromosome 
18 (~30% DBA2 and ~70% B6) suggests the presence of a trisomy of 
chromosome 18 (two copies of DBA2, one copy of B6). Figure S9. 
Distribution of relative gene expression from the B6 versus the DBA2 
allele in the B6D2F1 samples over autosomes, showing that the 
majority of genes have an equal expression from the B6 and DBA2 
allele. A log2 ratio of 0 represents equal biallelic gene expression from 
the B6 and DBA2 alleles, while positive and negative ratios represent 
higher expression from the B6 or DBA2 allele, respectively. On top the 
number of genes included in each of the boxplots. We obtained 
quantitative allelic information for up to 3,110 genes for the embryonic 
tissues, and up to 3,998 or 4,995 genes for the ESCs and EpiSCs, 
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respectively (out of a total of 21,345 unique RefSeq genes). For the 
ESC-PGA and EpiSC-PGA lines, for which our analysis is restricted to the 
heterozygous B6/ DBA2 parts of the genome as identified in Additional 
file 3: Table S2 and Additional file 4: Table S3, we obtained allele-specific 
quantification for between 2,514-2,994 genes (dependent on the line). 
The larger spread of allelic ratios as present in the embryonic tissues is 
likely due to the amplification procedure necessary during construction 
of the RNA-Seq library for the very small amounts of RNA obtained 
from the embryonic tissues. Figure S10: Example of the tag-normal-
ized RNA-Seq data over a selection of imprinted genes as included in 
this study. Figure S11. Validation of the H3K4me3 and H3K27me3 
ChIP-Seq performed on 3 B6D2F1 ESCs lines. Example of tag-normal-
ized ChIP-Seq data over known pluripotency markers as well as 
imprinted genes. For the highly expressed pluripotency markers, we 
detect clear H3K4me3 peaks on the promoters, but no H3K27me3, as 
expected. Dependent on the gene, the imprinted genes contain 
promoter-associated H3K4me3 (active), H3K27me3 (silent) or both 
(bivalent; associated with low level of expression) [48]. Figure S12. 
(Allelic) epigenetic landscape of fertilized ESC, ESC-NT and ESC-PGA 
lines, showing that the majority of the H3K4me3 and/or H3K27me3 
enriched loci associated with imprinted loci are equally present at both 
alleles. (a) Allelic bias of H3K4me3 or H3K27me3 enriched loci 
(ChIP-Seq “peaks”) associated with known imprinted genes plotted by 
the percentage of B6 as compared to the total coverage of B6 and 
DBA2 per peak. Within both individual panels, the left axis indicates that 
the peak is largely present on the DBA2 (paternal) allele, the right axis 
indicates that the peak is largely present on the B6 (maternal) allele, the 
middle axis indicated that the peak is equally present on both alleles. 
The left panel visualizes H3K4me3, the right panel represents 
H3K27me3. The graph only includes data points if (i) a gene was 
associated with a peak for H3K4me3 or H3K27me3 and (ii) the peak 
contained SNPs to discriminate between the DBA2 and B6 allele. Since 
only a minority of the imprinted genes shown are associated with 
H3K27me3 (see Additional file 2: Fig. S11), the H3K27me3 panel 
contains relatively few data points. “P” = paternally expressed; “M” = 
maternally expressed. (b) Quantification of ChIP-Seq peaks shown in 
panel (a). This panel additionally includes peaks that do not contain 
SNPs to determine allelic bias and could therefore not be included in 
panel (a). Figure S13. Allelic bias in expression of known imprinted 
genes as shown in Fig. 2a plotted by the percentage of B6 as compared 
to the total coverage of B6 and DBA2 (left) or the percentage of 129 as 
compared to the total coverage of 129 and Cast (right). Within both 
individual panels, the left axis represents expression from the paternal 
allele, the right axis represents expression from the maternal allele, the 
middle axis represents equal biallelic expression. The graph only 
includes data points of genes for which we obtained sufficient 
coverage to calculate allelic bias, explaining the variable number of 
data points between genes or the complete lack of data points for 
some genes in either of the cell lines. The left panel (data points in red) 
visualizes B6D2F1 ESC lines and is the same as shown in Fig. 2a. The 
individual replicas of all samples are included in the graph, but not 
individually labeled. The right panel (data points in gray and black) 
represents 129xCast ESC lines either derived and maintained in the 
presence of serum and LIF (black; 129CastF1) or adapted to 2i + LIF 
(gray; 129CastF1_2i) [42]. The 129CastF1 ESCs are previously referred to 
as ES_Tsix-stop [42]. “P” = paternally expressed; “M” = maternally 
expressed. Figure S14. Similar to Additional file 2: Fig. S13, showing 
allelic expression of imprinted genes during embryoid body (EB) 
differentiation of ESCs maintained in 2i+LIF (left; the same as Fig. 2b) or 
serum+LIF (right panel). Figure S15. Quantification of expression 
levels (RPKM) of the genes shown in Fig. 2a.This figure matches Fig. 2c, 
but additionally includes quantification of gene expression of B6D2F1 
embryonic tissues. Figure S16. Quantification of expression levels 
(RPKM) of Rian and Meg3, as well as Igf2 and Cdkn1c, representing 
imprinted genes misregulated in (a selection of ) B6D2F1 EpiSC-NT 
lines. Figure S17. DNA methylation analysis of Imprinted Control 
Regions (ICRs). Genome-wide DNA methylation profiles were 
generated using MethylCap-Seq. The four profiles were normalized to 
7,139,891 sequence tags to allow quantitative comparisons. ICR 
coordinates were obtained from Mikkelsen et al. [98] and 
Ferguson-Smith [99]. (a) DNA methylation over known ICRs in a 
genome browser view. For clarity, some of the ICRs are boxed. For the 
imprinted maternally expressed genes (ICR on paternal allele 
methylated), both PGA lines show a loss of DNA methylation as 
compared to the fertilized EpiSCs as expected for PGA lines. For the 
imprinted paternally expressed genes (ICR on maternal allele 
methylated), both PGA lines show ~2 fold increase in DNA methylation 
as compared to the fertilized EpiSCs as expected for PGA lines. Notably, 
for the ICRs for which there is one or more polymorphic site(s) to 
discriminate alleles, both EpiSC1 and EpiSC2 show the anticipated, 
monoallelic presence of DNA methylation on the expected allele (for 
Rasgrf1 (paternal) and Snrpn, Mcts2/ H13, Sgce/ Peg10, Plagl1 and 
Impact (all maternal) (data not shown)). (b) Quantification (on tag 
counts) of peaks as shown in panel (a), including the fold change of the 
peak in the EpiSC-PGAs as compared to the fertilized EpiSCs (yellow 
header; green indicates decrease of peak, red indicates increase of 
peak). Figure S18. B6/DBA2 ratio per gene over the linear X chromo-
some (the X-axis representing genomic coordinates in MB) ) in ESCs (a) 
or EpiSCs (b), similar to Fig. 4d. Each dot represents a gene. In blue the 
B6/DBA2 ratio obtained by DNA sequencing at 5MB resolution, 
confirming the presence of a B6 and DBA chromosome X in the female 
EpiSC1 and EpiSC-NT1 lines and the presence of a single B6 X 
chromosome in the male EpiSC2 and EpiSC3 lines. XIC = X inactivation 
center.
Additional file 3: Table S2. Genotype and breakpoints of the B6D2F1 
ESC-PGA lines used in this study as determined by RNA-Seq at 1 MB res-
olution. Red represents B6 on both alleles, blue represent heterozygous 
B6D2F1, yellow represents DBA2 on both alleles. A shift in genotype, 
indicated with a “,”, represents a recombination breakpoint that occurred 
in the B6D2F1 oocyte.
Additional file 4: Table S3. Genotype and breakpoints of the B6D2F1 
EpiSC-PGA lines as determined by genomic sequencing or RNA-Seq 
at 1 MB resolution. Red represents B6 on both alleles, blue represent 
heterozygous B6D2F1, yellow represents DBA2 on both alleles. A shift 
in genotype, indicated with a “,”, represents a recombination break-
point that occurred in the B6D2F1 oocyte. The RNA-Seq genotyping 
algorithm identifies the correct position of the genomic breakpoints 
in 47% (9 of 19) and 64% (14 of 22) of the cases in EpiSC-PGA1 and 
EpiSC-PGA2, respectively, with an average accuracy of 1.3MB (EpiSC-
PGA1) and 4.6MB (EpiSC-PGA2). The lower accuracy in EpiSC-PGA2 is 
mainly because three of the breakpoints are present in gene-poor loci 
where the RNA-Seq-based genotyping method lacks resolution. The 
distribution of relative expression from the B6 versus the DBA2 allele 
of the genes present within genomic regions genotyped as either 
homozygous B6, heterozygous B6/DBA2 or homozygous DBA2 of both 
EpiSC-PGA lines is present in Additional file 2: Fig. S7.
Additional file 5: Table S4. Compiled list of imprinted genes.
Additional file 6: Table S5. Allelic bias in expression of known 
imprinted genes shown as percentage of B6 as compared to the total 
coverage of B6 and DBA2 per gene. The table below includes gene 
expression values, read counts, allelic counts and standard error of 
the mean of the imprinted genes. For the upper part, the table only 
includes data points of genes for which we obtained sufficient cover-
age to calculate allelic bias, explaining the empty cells in the table.
Additional file 7: Table S6. Differential gene expression between ferti-
lized EpiSCs versus EpiSC-NTs or EpiSC-PGAs (adjusted p-value <0.05).
Additional file 8: Table S7. Genome-wide gene expression values, 
allelic counts and standard error of the mean for the RNA-Seq profiles 
generated in this study.
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